|
|
|
Insider
Information: |
Leung Sandra |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
348,885 |
|
Indirect Shares
|
100,721 |
|
|
Direct
Value |
$14,326,157 |
|
|
Indirect Value
|
$4,153,734 |
|
|
Total
Shares |
449,606 |
|
|
Total
Value |
$18,479,891 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
7.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Bristol-Myers Squibb Co |
BMY |
EVP, General Counsel |
2024-03-10 |
347,385 |
2024-03-10 |
100,721 |
Premium* |
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-02-17 |
1,500 |
2009-02-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
D |
$62.30 |
$409,623 |
D/D |
(6,575) |
272,171 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-02-17 |
4 |
OE |
$25.45 |
$381,750 |
D/D |
15,000 |
275,656 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
7,418 |
278,746 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
99,937 |
292,758 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
D |
$62.30 |
$1,424,053 |
D/D |
(22,858) |
293,397 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-06 |
4 |
D |
$65.12 |
$363,435 |
D/D |
(5,581) |
298,578 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,573 |
298,970 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,189 |
304,159 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-10 |
4 |
D |
$65.53 |
$463,101 |
D/D |
(7,067) |
305,139 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,997 |
307,535 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,631 |
308,072 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2022-06-06 |
4 |
S |
$74.89 |
$4,867,850 |
D/D |
(65,000) |
308,627 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-02-17 |
4 |
S |
$63.57 |
$645,342 |
D/D |
(10,152) |
309,547 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-06 |
4 |
D |
$64.71 |
$363,864 |
D/D |
(5,623) |
314,801 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,574 |
315,121 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
General Counsel & Secretary |
|
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
44,084 |
316,255 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-02-17 |
4 |
OE |
$22.73 |
$330,949 |
D/D |
14,560 |
319,699 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,303 |
320,424 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,082 |
324,623 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(70) |
326,026 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2023-11-21 |
4 |
D |
$48.75 |
$479,163 |
D/D |
(9,830) |
331,414 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2021-07-30 |
4 |
S |
$68.04 |
$1,999,696 |
D/D |
(29,390) |
339,967 |
0 |
% |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2023-03-10 |
4 |
D |
$65.71 |
$2,240,974 |
D/D |
(34,104) |
341,244 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2016-03-10 |
4 |
D |
$64.94 |
$2,064,378 |
D/D |
(31,789) |
344,507 |
0 |
- |
|
BMY |
Bristol-Myers Squibb Co |
EVP, General Counsel |
|
2024-03-10 |
4 |
D |
$53.79 |
$896,141 |
D/D |
(16,660) |
347,385 |
0 |
- |
|
133 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|